TY - JOUR
T1 - Delivery of cascade screening for hereditary conditions
T2 - A scoping review of the literature
AU - Roberts, Megan C.
AU - Dotson, W. David
AU - DeVore, Christopher S.
AU - Bednar, Erica M.
AU - Bowen, Deborah J.
AU - Ganiats, Theodore G.
AU - Green, Ridgely Fisk
AU - Hurst, Georgia M.
AU - Philp, Alisdair R.
AU - Ricker, Charité N.
AU - Sturm, Amy C.
AU - Trepanier, Angela M.
AU - Williams, Janet L.
AU - Zierhut, Heather A.
AU - Wilemon, Katherine A.
AU - Hampel, Heather
N1 - Publisher Copyright:
© 2018 Project HOPE- The People-to-People Health Foundation, Inc.
PY - 2018
Y1 - 2018
N2 - Cascade screening is the process of contacting relatives of people who have been diagnosed with certain hereditary conditions. Its purpose is to identify, inform, and manage those who are also at risk. We conducted a scoping review to obtain a broad overview of cascade screening interventions, facilitators and barriers to their use, relevant policy considerations, and future research needs. We searched for relevant peer-reviewed literature in the period 1990-2017 and reviewed 122 studies. Finally, we described 45 statutes and regulations related to the use and release of genetic information across the fifty states. We sought standardized best practices for optimizing cascade screening across various geographic and policy contexts, but we found none. Studies in which trained providers contacted relatives directly, rather than through probands (index patients), showed greater cascade screening uptake; however, policies in some states might limit this approach. Major barriers to cascade screening delivery include suboptimal communication between the proband and family and geographic barriers to obtaining genetic services. Few US studies examined interventions for cascade screening or used rigorous study designs such as randomized controlled trials. Moving forward, there remains an urgent need to conduct rigorous intervention studies on cascade screening in diverse US populations, while accounting for state policy considerations.
AB - Cascade screening is the process of contacting relatives of people who have been diagnosed with certain hereditary conditions. Its purpose is to identify, inform, and manage those who are also at risk. We conducted a scoping review to obtain a broad overview of cascade screening interventions, facilitators and barriers to their use, relevant policy considerations, and future research needs. We searched for relevant peer-reviewed literature in the period 1990-2017 and reviewed 122 studies. Finally, we described 45 statutes and regulations related to the use and release of genetic information across the fifty states. We sought standardized best practices for optimizing cascade screening across various geographic and policy contexts, but we found none. Studies in which trained providers contacted relatives directly, rather than through probands (index patients), showed greater cascade screening uptake; however, policies in some states might limit this approach. Major barriers to cascade screening delivery include suboptimal communication between the proband and family and geographic barriers to obtaining genetic services. Few US studies examined interventions for cascade screening or used rigorous study designs such as randomized controlled trials. Moving forward, there remains an urgent need to conduct rigorous intervention studies on cascade screening in diverse US populations, while accounting for state policy considerations.
UR - http://www.scopus.com/inward/record.url?scp=85046705020&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046705020&partnerID=8YFLogxK
U2 - 10.1377/hlthaff.2017.1630
DO - 10.1377/hlthaff.2017.1630
M3 - Article
C2 - 29733730
AN - SCOPUS:85046705020
SN - 0278-2715
VL - 37
SP - 801
EP - 808
JO - Health Affairs
JF - Health Affairs
IS - 5
ER -